Proprietary AI analyst is now available
- Public Comps
- Droga Raia
Droga Raia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Droga Raia and similar public comparables like Tsuruha Holdings, MatsukiyoCocokara, Alibaba Health, CR Pharmaceutical and more.
Droga Raia Overview
About Droga Raia
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.
Founded
2011
HQ

Employees
64.8K
Website
Sectors
Financials (LTM)
EV
$8B
Valuation Multiples
Start free trialDroga Raia Financials
Droga Raia reported last 12-month revenue of $9B and EBITDA of $702M.
In the same LTM period, Droga Raia generated $3B in gross profit, $702M in EBITDA, and $285M in net income.
Revenue (LTM)
Droga Raia P&L
In the most recent fiscal year, Droga Raia reported revenue of $9B and EBITDA of $686M.
Droga Raia is profitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 8%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Droga Raia Stock Performance
Droga Raia has current market cap of $6B, and enterprise value of $8B.
Market Cap Evolution
Droga Raia's stock price is $3.42.
Droga Raia share price decreased by 7.9% in the last 30 days, and increased by 19.8% in the last year.
Droga Raia has an EPS (earnings per share) of $0.15.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $6B | -1.9% | -7.9% | -27.4% | 19.8% | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDroga Raia Valuation Multiples
Droga Raia trades at 0.9x EV/Revenue multiple, and 10.8x EV/EBITDA.
EV / Revenue (LTM)
Droga Raia Financial Valuation Multiples
As of June 12, 2026, Droga Raia has market cap of $6B and EV of $8B.
Droga Raia has a P/E ratio of 21.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Droga Raia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Droga Raia Margins & Growth Rates
Droga Raia grew revenue by 8% and EBITDA by 11% in the last fiscal year.
In the most recent fiscal year, Droga Raia reported gross margin of 29%, EBITDA margin of 8%, and net margin of 3%.
Droga Raia Margins
Droga Raia Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Droga Raia Operational KPIs
Droga Raia's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Droga Raia's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Droga Raia's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Droga Raia Competitors
Droga Raia competitors include Tsuruha Holdings, MatsukiyoCocokara, Alibaba Health, CR Pharmaceutical, Yifeng Pharmacy, Jointown Pharmaceutical, Sugi Holdings, Nahdi Medical, Clicks Group and BrightSpring Health.
Most Droga Raia public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.7x | 0.5x | 9.7x | 8.8x | |||
| 0.8x | 0.7x | 7.9x | 7.6x | |||
| 1.2x | 1.1x | 23.1x | 18.6x | |||
| 0.3x | 0.3x | 3.9x | 4.1x | |||
| 0.8x | 0.8x | 4.6x | 4.7x | |||
| 0.2x | 0.2x | 4.8x | 5.4x | |||
| 0.5x | 0.5x | 7.5x | 7.3x | |||
| 1.3x | 1.2x | 7.4x | 7.5x | |||
This data is available for Pro users. Sign up to see all Droga Raia competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Droga Raia
| When was Droga Raia founded? | Droga Raia was founded in 2011. |
| Where is Droga Raia headquartered? | Droga Raia is headquartered in Brazil. |
| How many employees does Droga Raia have? | As of today, Droga Raia has over 64K employees. |
| Is Droga Raia publicly listed? | Yes, Droga Raia is a public company listed on B3. |
| What is the stock symbol of Droga Raia? | Droga Raia trades under RADL3 ticker. |
| When did Droga Raia go public? | Droga Raia went public in 1995. |
| Who are competitors of Droga Raia? | Droga Raia main competitors include Tsuruha Holdings, MatsukiyoCocokara, Alibaba Health, CR Pharmaceutical, Yifeng Pharmacy, Jointown Pharmaceutical, Sugi Holdings, Nahdi Medical, Clicks Group, BrightSpring Health. |
| What is the current market cap of Droga Raia? | Droga Raia's current market cap is $6B. |
| What is the current revenue of Droga Raia? | Droga Raia's last 12 months revenue is $9B. |
| What is the current revenue growth of Droga Raia? | Droga Raia revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Droga Raia? | Current revenue multiple of Droga Raia is 0.9x. |
| What is the current EBITDA of Droga Raia? | Droga Raia's last 12 months EBITDA is $702M. |
| What is Droga Raia's EBITDA margin? | Droga Raia's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Droga Raia? | Current EBITDA multiple of Droga Raia is 10.8x. |
| What is the current FCF of Droga Raia? | Droga Raia's last 12 months FCF is $154M. |
| What is Droga Raia's FCF margin? | Droga Raia's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Droga Raia? | Current FCF multiple of Droga Raia is 49.1x. |
| How many companies Droga Raia has acquired to date? | Droga Raia hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Droga Raia has invested to date? | Droga Raia hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Droga Raia
Lists including Droga Raia
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.